The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer's disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for ...
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...
(WNDU) - More than six million Americans are living with Alzheimer’s disease; it slowly steals your memories and takes away your mind. There is no cure yet, but now, a newly FDA-approved drug is ...
CLEVELAND, Ohio (Ivanhoe Newswire) – More than six million Americans are living with Alzheimer’s disease, it slowly steals ...
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition ...
Morningstar analyst Karen Andersen, CFA, discusses a recent report by her firm about the challenges faced by biopharma with ...
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
Currently there is no cure for Alzheimer's disease, a progressive neurological disease that slowly robs a person of their memory and personality and interferes with relationships. However, new drugs m ...
The Food and Drug Administration has laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar ...
More than 6 million Americans are living with Alzheimer’s disease. It slowly steals your memories and takes away your mind. There is no cure, yet, but now, a newly FDA-approved drug is helping ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical ...
